Additional Information

Tyrone Dowdy is an analytical chemist studying metabolic vulnerabilities in gliomas with a particular focus on IDH1-R132H mutated ones. His goals are to explore the mechanistic factors that sensitize gliomas to interventions involving metabolic reprogramming. His areas of expertise include drug discovery, lipidomic studies, quantitative LC-MS analysis, method development, and validation.